These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1279971)

  • 1. Deletion of the KIT and PDGFRA genes in a patient with piebaldism.
    Spritz RA; Droetto S; Fukushima Y
    Am J Med Genet; 1992 Nov; 44(4):492-5. PubMed ID: 1279971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A YAC contig spanning a cluster of human type III receptor protein tyrosine kinase genes (PDGFRA-KIT-KDR) in chromosome segment 4q12.
    Spritz RA; Strunk KM; Lee ST; Lu-Kuo JM; Ward DC; Le Paslier D; Altherr MR; Dorman TE; Moir DT
    Genomics; 1994 Jul; 22(2):431-6. PubMed ID: 7528718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Organization and nucleotide sequence of the human KIT (mast/stem cell growth factor receptor) proto-oncogene.
    Giebel LB; Strunk KM; Holmes SA; Spritz RA
    Oncogene; 1992 Nov; 7(11):2207-17. PubMed ID: 1279499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human piebald trait resulting from a dominant negative mutant allele of the c-kit membrane receptor gene.
    Fleischman RA
    J Clin Invest; 1992 Jun; 89(6):1713-7. PubMed ID: 1376329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion of the c-kit protooncogene in the human developmental defect piebald trait.
    Fleischman RA; Saltman DL; Stastny V; Zneimer S
    Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10885-9. PubMed ID: 1720553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet-derived growth factor receptor family mutations in gastrointestinal stromal tumours.
    Sihto H; Franssila K; Tanner M; Vasama-Nolvi C; Sarlomo-Rikala M; Nupponen NN; Joensuu H; Isola J
    Scand J Gastroenterol; 2006 Jul; 41(7):805-11. PubMed ID: 16785193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations of the KIT (mast/stem cell growth factor receptor) proto-oncogene account for a continuous range of phenotypes in human piebaldism.
    Spritz RA; Holmes SA; Ramesar R; Greenberg J; Curtis D; Beighton P
    Am J Hum Genet; 1992 Nov; 51(5):1058-65. PubMed ID: 1384325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A novel KIT gene mutation from a family with piebaldism in the southern part of China].
    Deng WP; Huang YS; Lu C; Lan W; Zhu GX; Lin QD; Feng PY
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Dec; 22(6):668-70. PubMed ID: 16331568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic organization of the human c-kit gene: evolution of the receptor tyrosine kinase subclass III.
    André C; Martin E; Cornu F; Hu WX; Wang XP; Galibert F
    Oncogene; 1992 Apr; 7(4):685-91. PubMed ID: 1373482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A novel KIT gene mutation results in piebaldism].
    Deng WP; Lu C; Zhu GX; Lin QD; Feng PY
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Oct; 22(5):545-7. PubMed ID: 16220461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KIT and platelet-derived growth factor receptor alpha tyrosine kinase gene mutations and KIT amplifications in human solid tumors.
    Sihto H; Sarlomo-Rikala M; Tynninen O; Tanner M; Andersson LC; Franssila K; Nupponen NN; Joensuu H
    J Clin Oncol; 2005 Jan; 23(1):49-57. PubMed ID: 15545668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel mutations of the KIT (mast/stem cell growth factor receptor) proto-oncogene in human piebaldism.
    Spritz RA; Holmes SA; Itin P; Küster W
    J Invest Dermatol; 1993 Jul; 101(1):22-5. PubMed ID: 7687267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dominant negative and loss of function mutations of the c-kit (mast/stem cell growth factor receptor) proto-oncogene in human piebaldism.
    Spritz RA; Giebel LB; Holmes SA
    Am J Hum Genet; 1992 Feb; 50(2):261-9. PubMed ID: 1370874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein expression of KIT and gene mutation of c-kit and PDGFRs in Ewing sarcomas.
    Do I; Araujo ES; Kalil RK; Bacchini P; Bertoni F; Unni KK; Park YK
    Pathol Res Pract; 2007; 203(3):127-34. PubMed ID: 17298867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel mutations and deletions of the KIT (steel factor receptor) gene in human piebaldism.
    Ezoe K; Holmes SA; Ho L; Bennett CP; Bolognia JL; Brueton L; Burn J; Falabella R; Gatto EM; Ishii N
    Am J Hum Genet; 1995 Jan; 56(1):58-66. PubMed ID: 7529964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product.
    Furitsu T; Tsujimura T; Tono T; Ikeda H; Kitayama H; Koshimizu U; Sugahara H; Butterfield JH; Ashman LK; Kanayama Y
    J Clin Invest; 1993 Oct; 92(4):1736-44. PubMed ID: 7691885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure, organization, and transcription units of the human alpha-platelet-derived growth factor receptor gene, PDGFRA.
    Kawagishi J; Kumabe T; Yoshimoto T; Yamamoto T
    Genomics; 1995 Nov; 30(2):224-32. PubMed ID: 8586421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human piebaldism: six novel mutations of the proto-oncogene KIT.
    Syrris P; Heathcote K; Carrozzo R; Devriendt K; Elçioglu N; Garrett C; McEntagart M; Carter ND
    Hum Mutat; 2002 Sep; 20(3):234. PubMed ID: 12204004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation of the KIT (mast/stem cell growth factor receptor) protooncogene in human piebaldism.
    Giebel LB; Spritz RA
    Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8696-9. PubMed ID: 1717985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel KIT mutation results in piebaldism with progressive depigmentation.
    Richards KA; Fukai K; Oiso N; Paller AS
    J Am Acad Dermatol; 2001 Feb; 44(2):288-92. PubMed ID: 11174389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.